Navigation Links
Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
Date:4/21/2008

ch 31, 2008 and

December 31, 2007, respectively 2.1 2.1

Additional paid-in capital 2,223.9 2,210.8

Retained earnings 2,177.9 2,057.7

Accumulated other comprehensive income 51.6 25.3

Treasury stock, at cost; 19.3 and 19.7 shares

at March 31, 2008 and December 31, 2007,

respectively (953.5) (971.7)

Total stockholders' equity 3,502.0 3,324.2

Total liabilities and stockholders' equity $8,646.3 $8,565.7

Quest Diagnostics Incorporated and Subsidiaries

Consolidated Statements of Cash Flows

For the Three Months Ended March 31, 2008 and 2007

(in millions)

(unaudited)

Three Months Ended

March 31,

2008 2007

Cash flows from operating activities:

Net income $139.6 $105.9

Adjustments to reconcile net income

to net cash provided by operating activities:

Depreciation and amortization 65.3 50.3

Provision for doubtful accounts 86.0 67.5

Stock-based compensation expense 21.2 16.1

Deferred income tax benefit (2.6) (8.8)

Minority share of income 7.1 6.1

Excess tax benefits from stock-based

compensation arrangements (0.6) (4.2)

Other, net
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
2. Susan G. Komen for the Cure Advocacy Alliance Suggests Questions for Tonights Presidential Debate
3. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
4. Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
5. New conference tackles the tough questions in lung cancer
6. The Quest for Americas Life in Beautiful Smiles: Captured in Photography
7. SurgiQuest Announces First Procedure Using AirSeal(TM) Access System
8. Study questions cost of complexity in evolution
9. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
10. Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds
11. Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 2Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 4Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 4Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3HealthFitness Announces Third Quarter 2009 Financial Results 60712 1HealthFitness Announces Third Quarter 2009 Financial Results 60712 2HealthFitness Announces Third Quarter 2009 Financial Results 60712 3HealthFitness Announces Third Quarter 2009 Financial Results 60712 4HealthFitness Announces Third Quarter 2009 Financial Results 60712 5HealthFitness Announces Third Quarter 2009 Financial Results 60712 6HealthFitness Announces Third Quarter 2009 Financial Results 60712 7HealthFitness Announces Third Quarter 2009 Financial Results 60712 8HealthFitness Announces Third Quarter 2009 Financial Results 60712 9HealthFitness Announces Third Quarter 2009 Financial Results 60712 10HealthFitness Announces Third Quarter 2009 Financial Results 60712 11Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 1Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 2Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 3Zyngenia Inc Raises 2410 Million in Series A Funding 14724 1Zyngenia Inc Raises 2410 Million in Series A Funding 14724 2Zyngenia Inc Raises 2410 Million in Series A Funding 14724 3Zyngenia Inc Raises 2410 Million in Series A Funding 14724 4